Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ajanta Pharma Limited (AJANTPHARM.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
1,260.95+25.35 (+2.05%)
At close: 03:29PM IST
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Total Revenue
33,409,900
33,409,900
28,470,200
25,618,000
20,164,500
Cost of Revenue
8,322,700
8,322,700
6,823,900
6,902,300
4,235,000
Gross Profit
25,087,200
25,087,200
21,646,300
18,715,700
15,929,500
Operating Expense
17,047,200
17,047,200
12,723,900
12,611,000
10,898,900
Operating Income
8,040,000
8,040,000
8,922,400
6,104,700
5,030,600
Net Non Operating Interest Income Expense
-102,000
-102,000
-47,600
-108,500
7,500
Pretax Income
9,094,800
9,094,800
9,001,800
6,639,700
5,142,700
Tax Provision
1,968,000
1,968,000
2,463,100
1,962,700
1,273,000
Net Income Common Stockholders
7,126,800
7,126,800
6,538,700
4,677,000
3,869,700
Average Dilution Earnings
-
-
0
-
-
Diluted NI Available to Com Stockholders
7,126,800
7,126,800
6,538,700
4,677,000
3,869,700
Basic EPS
-
-
50.06
35.73
29.31
Diluted EPS
-
-
50.06
35.73
29.31
Basic Average Shares
-
-
130,617
130,888
132,002
Diluted Average Shares
-
-
130,623
130,898
132,022
Rent Expense Supplemental
-
-
24,300
20,200
175,700
Total Expenses
25,369,900
25,369,900
19,547,800
19,513,300
15,133,900
Net Income from Continuing & Discontinued Operation
7,126,800
7,126,800
6,538,700
4,677,000
3,869,700
Normalized Income
7,126,800
7,126,800
6,519,886
4,820,627
3,831,398
Interest Income
-
-
35,100
10,600
19,100
Interest Expense
102,000
102,000
82,700
119,100
11,600
Net Interest Income
-102,000
-102,000
-47,600
-108,500
7,500
EBIT
9,196,800
9,196,800
9,084,500
6,758,800
5,154,300
EBITDA
10,449,800
-
-
-
-
Reconciled Cost of Revenue
8,322,700
8,322,700
6,823,900
6,902,300
4,235,000
Reconciled Depreciation
1,253,000
1,253,000
1,160,900
957,200
720,800
Net Income from Continuing Operation Net Minority Interest
7,126,800
7,126,800
6,538,700
4,677,000
3,869,700
Total Unusual Items Excluding Goodwill
-
-
25,900
-203,900
50,900
Total Unusual Items
-
-
25,900
-203,900
50,900
Normalized EBITDA
10,449,800
10,449,800
10,219,500
7,919,900
5,824,200
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
7,086
-60,273
12,598
Advertisement
Advertisement